ETF와이어ETF·펀드·패시브 투자, 매일 5분으로
etf1 min

Newon Cissus Extract Shown to Increase GLP-1 Secretion in Human Trial

Published: · Source: mk.co.kr

Newon Cissus Extract Shown to Increase GLP-1 Secretion in Human Trial
TL;DR: Newon said on the 15th that its individually recognized Cissus extract increased secretion of GLP-1, an appetite-regulating hormone, in a human application trial.

Global lifecare company Newon said on the 15th that its individually recognized ingredient, Cissus extract, was confirmed through a human application trial to increase secretion of glucagon-like peptide-1 (GLP-1), an appetite-regulating hormone. The company said the findings were published in an international academic journal. GLP-1 is known as a hormone related to appetite regulation, and Newon emphasized that the effect of Cissus extract was confirmed in a human trial. The publication is expected to help share the ingredient’s functional research results externally. Source: mk.co.kr

Partner picks

Relevant partner links for this story

A lightweight commerce block designed to add monetization without breaking reading flow.

This module may include affiliate links that earn a commission from qualifying purchases. ETF와이어

Related stories